| Financial Year |
March 31 2023 |
| Monetary Funds |
1,450,056,023.85 |
| Held-for-trading Financial Assets |
15,000,000.00 |
| Notes Receivable |
47,778,286.45 |
| Accounts Receivable |
190,141,634.24 |
| Advances to Suppliers |
25,348,945.64 |
| Other Receivables |
1,697,312.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
325,858,728.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,601,249.47 |
| Total Current Assets |
2,172,621,578.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
106,507,697.58 |
| Investment Properties |
-- |
| Fixed Assetes |
1,091,546,682.06 |
| Under-construction Projects |
179,489,318.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
205,223,062.25 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,369,225.69 |
| Deferred Income Tax Assets |
22,272,714.76 |
| Other Non-Current Assets |
29,182,908.23 |
| Sub-Total of Non-Current Assets |
1,654,477,941.35 |
| Total Assets |
3,827,099,519.59 |
| Short-Term Loans |
209,207,013.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
172,731,581.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,647,531.21 |
| Taxes Payable |
23,052,146.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,272,651.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
51,045,897.92 |
| Other Current Liabilities |
1,220,641.86 |
| Sub-Total of Current Liabilities |
498,567,017.42 |
| Long-term Loans |
25,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
98,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,721,546.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
152,630,921.49 |
| Total Liabilities |
651,197,938.91 |
| Paid-In Capital(Or Share Stock) |
363,419,860.00 |
| Capital Surplus |
1,889,647,416.36 |
| Surplus Reserve |
40,339,072.58 |
| LESS:Treasury Stock |
35,446,469.68 |
| Undistributed Profits |
682,553,889.39 |
| Minority Stockholder's Interest |
235,387,812.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,940,513,768.65 |
| Owner's Equity（Stockholder's Equity） |
3,175,901,580.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,827,099,519.59 |
